Interactions between prion protein (PrP) and tau protein have long been discussed, especially in relation to the pathogenesis of neurodegenerative diseases. The presence of tauopathy in the genetic forms of Creutzfeldt-Jakob disease (CJD) brains is not uncommon. Molecular interactions between PrP and tau protein have been demonstrated in animal models; the role is attributed to the structural properties of misfolded isoform of the host-encoded prion protein (PrPSc) aggregates, especially amyloid, which contributes to the phosphorylation of tau protein, which is reflected in the frequent occurrence of tau pathology in inherited prion amyloidoses. The question is the relationship between PrPSc and hippocampal tau pathology without amyloid deposits (i.e. PART and ARTAG) in sporadic CJD (sCJD). The co-occurrence of these two proteinopathies in sCJD brains is quite rare. These pathological entities have been described in only a few cases of sCJD, all of them were older than 70 years. There have been speculations about the possibility of accelerating the course of pre-existing tauopathy or the possibility of accelerating the ageing process in the CJD brains. Here we present the clinical course and neuropathological findings of a patient with sCJD in whom the above mentioned tauopathies PART and ARTAG, considered to be typical for older age, were found as early as 58 years of age. According to the available information, this case represents an unusually early occurrence of age-related tauopathies not only in relation to sCJD, but also in general.

Department of Neurology Faculty of Medicine and Dentistry Palacky University Olomouc Czech Republic

Department of Neurology University Hospital Palacky University Olomouc Czech Republic

Department of Pathology and Molecular Medicine 3 Faculty of Medicine Charles University and Thomayer Hospital Prague Czech Republic

Department of Pathology and Molecular Medicine 3rd Faculty of Medicine Charles University and Thomayer Hospital Prague Czech Republic

See more in PubMed

Gambetti P, Dong Z, Yuan J, et al. A novel human disease with abnormal prion protein sensitive to protease. Ann Neurol. 2008;63:677–708. PubMed PMC

Kovacs GG, Budka H.. Molecular pathology of human prion diseases. Int J Mol Sci. 2009;10:976–999. PubMed PMC

Parchi P, Saverioni D. Molecular pathology, classification and diagnosis of sporadic human prion disease variants. Folia Neuropathol. 2012;50:20–45. PubMed

Ghetti B, Piccardo P, Zanusso G. Dominantly inherited prion protein cerebral amyloidoses – a modern view of Gerstmann-Sträussler-Scheinker. Handb Clin Neurol. 2018;153:243–269. PubMed

Baiardi S, Rossi M, Capellari S, et al. Recent advances in the histo-molecular pathology of human prion disease. Brain Pathol. 2019;29(2):278–300. PubMed PMC

Miguelez-Rodriguez A, Santos-Juanes J, Vicente-Etxenausia I, et al. Brains with sporadic Creutzfeldt-Jacob disease copathology showed a prolonged end-stage of disease. J Clin Pathol. 2018;71(5):446–450. PubMed

Kovacs GG, Rahimi J, Ströbel T, et al. Tau pathology in Creutzfeldt-Jakob disease revisited. Brain Pathol. 2017;27(3):332–344. PubMed PMC

Crary JF, Trojanowski JQ, Schneider JA, et al. Primary age-related tauopathy (PART): a common pathology associated with human aging. Acta Neuropathol. 2014;128:755–756. PubMed PMC

Kovacs GG, Ferrer I, Grinberg LT, et al. Aging-related tau astrogliopathy (ARTAG): harmonized evaluation strategy. Acta Neuropathol. 2016;131:87–102. PubMed PMC

Lattanzio F, Abu-Rumeileh S, Franceschini A, et al. Prion-specific and surrogate CSF biomarkers in Creutzfeldt-Jakob disease: diagnostic accuracy in relation to molecular subtypes and analysis of neuropathological correlates of p-tau and Aβ42 levels. Acta Neuropathol. 2017;133:559–578. PubMed PMC

Reiniger L, Lukic A, Linehan J, et al. Tau, prions and Aβ: the triad of neurodegeneration. Acta Neuropathol. 2011;121:5–20. PubMed PMC

Sikorska B, Liberski PP, Sobow T, et al. Ultrastructural study of florid plaques in variant Creutzfeldt– jakob disease: a comparison with amyloid plaques in kuru, sporadic Creutzfeldt–Jakob disease and Gerstmann–Straussler– scheinker disease. Neuropathol Appl Neurobiol. 2009;35:46–59. PubMed

Braak H, Braak E, Bohl J. Staging of Alzheimer-related cortical destruction. Eur Neurol. 1993;33:403–408. PubMed

Braak H, Braak E. Staging of Alzheimer’s disease-related neurofibrillary changes. Neurobiol Aging. 1995;(1995(16):271–278. PubMed

Han J, Zhang J, Yao H, et al. Study on interaction between mikrotubule associated protein tau and prion protein. Life Sci. 2006;49(5):473–479. PubMed

Zerr I, Kallenberg K, Summers DM, et al. Updated clinical diagnostic criteria for sporadic Creutzfeldt-Jakob disease. Brain. 2012;132:2659–2666. PubMed PMC